glp-1 microdosing research is popular, but there's little evidence it works Microdosing GLP-1: A Next-Generation Approach

doi: 10.1001/jamainternmed.2013.2720 221 KnapenLMvan DalemJKeulemansYCvan ErpNPBazelierMTDe BruinMLet al

The Longevity Benefits of GLP-1 Medications GLP-1 receptor agonists like Ozempic and Mounjaro are showing promise not only for diabetes and weight management but also for broader health and longevity benefits

Step 5: Little to No Product Delivery If you receive anything at all, its usually: A generic, unbranded patch No ingredient list No instructions from a licensed source No quality control or safety warnings Most users report no results, or worseskin irritation or no absorption

The GLP-1R/GIPR/GcgR triple-agonist retatrutide achieves body weight loss (~25%) in just two-thirds of the time, potentially surpassing the efficacy of Roux-en-Y gastric bypass [29]

butyricum supplementation improved constipation and overall gut health markers in elderly patients, though weight loss was not measured

This is theoretical